Moyamoya: Epidemiology, Presentation, and Diagnosis

Neurosurgery Clinics of North America

Volumn 21, Issue 3, 2010, Pages 543-551

  Smith, Edward R ^a   Scott, R Michael ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Diagnosis; Epidemiology; Moyamoya; Natural history; Stroke

Indexed keywords

BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN SURGERY; CHOREA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; HEADACHE; HUMAN; MOYAMOYA DISEASE; NOMENCLATURE; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCREENING; SEIZURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; TRANSIENT ISCHEMIC ATTACK;

BRAIN ISCHEMIA; CAROTID STENOSIS; CEREBRAL ARTERIES; CEREBRAL REVASCULARIZATION; CHILD; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; MOYAMOYA DISEASE; STROKE;

EID: 77953763341     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2010.03.007     Document Type: Review

References (79)

1. Scott R.M., Smith E.R. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009, 360(12):1226-1237.
2. Soriano S.G., Sethna N.F., Scott R.M. Anesthetic management of children with moyamoya syndrome. Anesth Analg 1993, 77(5):1066-1070.
3. Nagaraja D., Verma A., Taly A.B., et al. Cerebrovascular disease in children. Acta Neurol Scand 1994, 90(5):251-255.
4. Takeuchi K., Shimizu K. Hypoplasia of the bilateral internal carotid arteries. Brain Nerve 1957, 9:37-43.
5. Suzuki J., Takaku A. Cerebrovascular " moyamoya" disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969, 20(3):288-299.
6. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997, 99(Suppl 2):S238-S240.
7. Kelly M.E., Bell-Stephens T.E., Marks M.P., et al. Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis 2006, 22(2-3):109-115.
8. Smith E.R., Scott R.M. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 2008, 24(2):E17.
9. Caldarelli M., Di Rocco C., Gaglini P. Surgical treatment of moyamoya disease in pediatric age. J Neurosurg Sci 2001, 45(2):83-91.
10. Suzuki J., Kodama N. Moyamoya disease-a review. Stroke 1983, 14(1):104-109.
11. Baba T., Houkin K., Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2007, 79(8):900-904.
12. Wakai K., Tamakoshi A., Ikezaki K., et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 1997, 99(Suppl 2):S1-S5.
13. Han D.H., Nam D.H., Oh C.W. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg 1997, 99(Suppl 2):S151-S155.
14. Han D.H., Kwon O.K., Byun B.J., et al. A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 2000, 142(11):1263-1273. [discussion: 1273-4].
15. Scott R.M., Smith J.L., Robertson R.L., et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004, 100(2 Suppl Pediatrics):142-149.
16. Yonekawa Y., Ogata N., Kaku Y., et al. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg 1997, 99(Suppl 2):S58-S60.
17. Uchino K., Johnston S.C., Becker K.J., et al. Moyamoya disease in Washington State and California. Neurology 2005, 65(6):956-958.
18. Fukui M., Kono S., Sueishi K., et al. Moyamoya disease. Neuropathology 2000, 20(Suppl):S61-S64.
19. Ikeda H., Sasaki T., Yoshimoto T., et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999, 64(2):533-537.
20. Nanba R., Tada M., Kuroda S., et al. Sequence analysis and bioinformatics analysis of chromosome 17q25 in familial moyamoya disease. Childs Nerv Syst 2005, 21(1):62-68.
21. Inoue T.K., Ikezaki K., Sasazuki T., et al. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000, 15:179-182.
22. Inoue T.K., Ikezaki K., Sasazuki T., et al. Analysis of class II genes of human leukocyte antigen in patients with moyamoya disease. Clin Neurol Neurosurg 1997, 99(Suppl 2):S234-S237.
23. Han H., Pyo C.W., Yoo D.S., et al. Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population. J Korean Med Sci 2003, 18(6):876-880.
24. Sakurai K., Horiuchi Y., Ikeda H., et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004, 49(5):278-281.
25. Tanghetti B., Capra R., Giunta F., et al. Moyamoya syndrome in only one of two identical twins. Case report. J Neurosurg 1983, 59(6):1092-1094.
26. Karasawa J., Touho H., Ohnishi H., et al. Cerebral revascularization using omental transplantation for childhood moyamoya disease. J Neurosurg 1993, 79(2):192-196.
27. Lubman D.I., Pantelis C., Desmond P., et al. Moyamoya disease in a patient with schizophrenia. J Int Neuropsychol Soc 2003, 9(5):806-810.
28. Miyamoto S., Kikuchi H., Karasawa J., et al. Study of the posterior circulation in moyamoya disease. Part 2: visual disturbances and surgical treatment. J Neurosurg 1986, 65(4):454-460.
29. Yilmaz E.Y., Pritz M.B., Bruno A., et al. Moyamoya: Indiana University Medical Center experience. Arch Neurol 2001, 58(8):1274-1278.
30. Ikezaki K., Han D.H., Kawano T., et al. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 1997, 28(12):2513-2517.
31. Hallemeier C.L., Rich K.M., Grubb R.L., et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 2006, 37(6):1490-1496.
32. Nishimoto A, Ueta K, Onbe H. Cooperative study on moyamoya disease in Japan. Abstracts of the 10th meeting on surgery for stroke. Tokyo: Nyuuron-sha; 1981. p. 53-8.
33. Seol H.J., Wang K.C., Kim S.K., et al. Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg 2005, 103(Suppl 5):439-442.
34. Hankinson T.C., Bohman L.E., Heyer G., et al. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. J Neurosurg Pediatr 2008, 1(3):211-216.
35. Ullrich N.J., Robertson R., Kinnamon D.D., et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007, 68(12):932-938.
36. Jea A., Smith E.R., Robertson R., et al. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 2005, 116(5):e694-e701.
37. Smith E.R., McClain C.D., Heeney M., et al. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus 2009, 26(4):E10.
38. Ohaegbulam C., Magge S., Scott R.M. Moyamoya syndrome. Pediatric neurosurgery 2001, 1077-1092. WB Saunders, Philadelphia. D. McLone (Ed.).
39. Imaizumi T., Hayashi K., Saito K., et al. Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 1998, 18(4):321-325.
40. Kuroda S., Ishikawa T., Houkin K., et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005, 36(10):2148-2153.
41. Choi J.U., Kim D.S., Kim E.Y., et al. Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 1997, 99(Suppl 2):S11-S18.
42. Kurokawa T., Chen Y.J., Tomita S., et al. Cerebrovascular occlusive disease with and without the moyamoya vascular network in children. Neuropediatrics 1985, 16(1):29-32.
43. Ezura M., Takahashi A., Yoshimoto T. Successful treatment of an arteriovenous malformation by chemical embolization with estrogen followed by conventional radiotherapy. Neurosurgery 1992, 31(6):1105-1107.
44. Fung L.W., Thompson D., Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005, 21(5):358-364.
45. Fukuyama Y., Umezu R. Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of Willis (" moyamoya" disease) in children. Brain Dev 1985, 7(1):21-37.
46. Maki Y., Enomoto T. Moyamoya disease. Childs Nerv Syst 1988, 4(4):204-212.
47. Shin I.S., Cheng R., Pordell G.R. Striking CT scan findings in a case of unilateral moyamoya disease-a case report. Angiology 1991, 42(8):665-671.
48. Fujita K., Shirakuni T., Kojima N., et al. Magnetic resonance imaging in moyamoya disease. No Shinkei Geka 1986, 14(Suppl 3):324-330.
49. Chabbert V., Ranjeva J.P., Sevely A., et al. Diffusion- and magnetisation transfer-weighted MRI in childhood moya-moya. Neuroradiology 1998, 40(4):267-271.
50. Fujiwara H., Momoshima S., Kuribayashi S. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 2005, 55(2):224-230.
51. Yamada I., Matsushima Y., Suzuki S. Moyamoya disease: diagnosis with three-dimensional time-of-flight MR angiography. Radiology 1992, 184(3):773-778.
52. Sunaga Y., Fujinaga T., Ohtsuka T. MRI findings of moyamoya disease in children. No To Hattatsu 1992, 24(4):375-379.
53. Brady A.P., Stack J.P., Ennis J.T. Moyamoya disease-imaging with magnetic resonance. Clin Radiol 1990, 42(2):138-141.
54. Rolak L.A. Magnetic resonance imaging in moyamoya disease. Arch Neurol 1989, 46(1):14.
55. Bruno A., Yuh W.T., Biller J., et al. Magnetic resonance imaging in young adults with cerebral infarction due to moyamoya. Arch Neurol 1988, 45(3):303-306.
56. Yamada I., Suzuki S., Matsushima Y. Moyamoya disease: diagnostic accuracy of MRI. Neuroradiology 1995, 37(5):356-361.
57. Yamada I., Suzuki S., Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 1995, 196(1):211-218.
58. Katz D.A., Marks M.P., Napel S.A., et al. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology 1995, 195(2):445-449.
59. Takanashi J.I., Sugita K., Niimi H. Evaluation of magnetic resonance angiography with selective maximum intensity projection in patients with childhood moyamoya disease. Eur J Paediatr Neurol 1998, 2(2):83-89.
60. Chang K.H., Yi J.G., Han M.H., et al. MR imaging findings of moyamoya disease. J Korean Med Sci 1990, 5(2):85-90.
61. Robertson R.L., Chavali R.V., Robson C.D., et al. Neurologic complications of cerebral angiography in childhood moyamoya syndrome. Pediatr Radiol 1998, 28(11):824-829.
62. Nomura S., Kashiwagi S., Uetsuka S., et al. Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst 2001, 17(4-5):270-274.
63. Takase K., Kashihara M., Hashimoto T. Transcranial Doppler ultrasonography in patients with moyamoya disease. Clin Neurol Neurosurg 1997, 99(Suppl 2):S101-S105.
64. Morgenstern C., Griewing B., Muller-Esch G., et al. Transcranial power-mode duplex ultrasound in two patients with moyamoya syndrome. J Neuroimaging 1997, 7(3):190-192.
65. Takeuchi S., Tanaka R., Ishii R., et al. Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method. Surg Neurol 1985, 23(5):468-474.
66. Nambu K., Suzuki R., Hirakawa K. Cerebral blood flow: measurement with xenon-enhanced dynamic helical CT. Radiology 1995, 195(1):53-57.
67. Liu H.M., Peng S.S., Li Y.W. The preoperative and postoperative cerebral blood flow and vasoreactivity in childhood moyamoya disease. Keio J Med 2000, 49(Suppl 1):A86-A89.
68. Shirane R., Yoshida Y., Takahashi T., et al. Assessment of encephalo-galeo-myo-synangiosis with dural pedicle insertion in childhood moyamoya disease: characteristics of cerebral blood flow and oxygen metabolism. Clin Neurol Neurosurg 1997, 99(Suppl 2):S79-S85.
69. Khan N., Yonekawa Y. Moyamoya angiopathy in Europe. Acta Neurochir Suppl 2005, 94:149-152.
70. Ikezaki K., Matsushima T., Kuwabara Y., et al. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994, 81(6):843-850.
71. Gebreyohanns M., Adams R.J. Sickle cell disease: primary stroke prevention. CNS Spectr 2004, 9(6):445-449.
72. Kodama N., Aoki Y., Hiraga H., et al. Electroencephalographic findings in children with moyamoya disease. Arch Neurol 1979, 36(1):16-19.
73. Kirkham F.J., DeBaun M.R. Stroke in children with sickle cell disease. Curr Treat Options Neurol 2004, 6(5):357-375.
74. Roach E.S. Etiology of stroke in children. Semin Pediatr Neurol 2000, 7(4):244-260.
75. Rosser T.L., Vezina G., Packer R.J. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology 2005, 64(3):553-555.
76. Kitahara T., Ariga N., Yamaura A., et al. Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry 1979, 42(3):208-214.
77. Sogaard I., Jorgensen J. Familial occurrence of bilateral intracranial occlusion of the internal carotid arteries (Moya Moya). Acta Neurochir (Wien) 1975, 31(3-4):245-252.
78. Hamada J.I., Yoshioka S., Nakahara T., et al. Clinical features of moyamoya disease in sibling relations under 15 years of age. Acta Neurochir (Wien) 1998, 140(5):455-458.
79. Roach E.S., Golomb M.R., Adams R., et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008, 39(9):2644-2691.